Roche Holding’s (ROG) “Buy” Rating Reaffirmed at JPMorgan Chase & Co.

JPMorgan Chase & Co. reiterated their buy rating on shares of Roche Holding Ltd. (VTX:ROG) in a research note issued to investors on Tuesday.

A number of other equities analysts have also commented on the stock. Citigroup Inc. reaffirmed a buy rating on shares of Roche Holding in a research note on Friday, July 1st. Goldman Sachs Group Inc. reissued a buy rating on shares of Roche Holding in a research note on Tuesday, July 19th.

Roche Holding (VTX:ROG) opened at 240.70 on Tuesday. The stock has a market capitalization of CHK 205.12 billion and a price-to-earnings ratio of 22.17. Roche Holding has a 12-month low of CHK 229.90 and a 12-month high of CHK 281.40. The company has a 50-day moving average price of CHK 242.12 and a 200-day moving average price of CHK 245.99.

About Roche Holding

Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.